PuraCath Medical Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $471K
Latest Deal Amount
  • Investors
  • 13

PuraCath Medical General Information

Description

Developer of a dialysis disinfection device designed to reduce infectious complications associated with catheter connections. The company's device uses proprietary UV technology to keep patients healthy and protected from infection while minimizing dependence on user compliance, enabling healthcare providers to improve dialysis patients' quality of life by reducing infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Primary Office
  • 660 4th Street
  • Suite 104
  • San Francisco, CA 94107
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PuraCath Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 23-Jun-2020 $471K 00.000 000.00 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2017 00.000 Completed Generating Revenue
6. Grant 01-Jan-2017 00000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A1) 31-Jan-2016 000 00.000 0000 Completed Generating Revenue
4. Grant 02-Jun-2015 00.000 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 06-May-2013 00000 00000 00.000 Completed Startup
2. Grant 01-Jan-2012 $650K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view PuraCath Medical’s complete valuation and funding history, request access »

PuraCath Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view PuraCath Medical’s complete cap table history, request access »

PuraCath Medical Executive Team (8)

Name Title Board Seat Contact Info
Julia Rasooly Founder, Chief Executive Officer, President & Board Member
Michael Fourkas Vice President, Research & Development
Larry Yost Marketing Advisor
Don Canal Quality and Regulatory Affairs Advisor
You’re viewing 4 of 8 executive team members. Get the full list »

PuraCath Medical Board Members (4)

Name Representing Role Since
Julia Rasooly PuraCath Medical Founder, Chief Executive Officer, President & Board Member 000 0000
Michael Rasooly PuraCath Medical Board Member 000 0000
Richard Ferrari Self Board Member & Business Advisor 000 0000
You’re viewing 3 of 4 board members. Get the full list »

PuraCath Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gregory Schears Angel (individual) Minority 000 0000 000000 0
Richard Ferrari Angel (individual) Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »